Z79.810 - Long term (current) use of selective estrogen receptor modulators (SERMs)

Applicable to Long term (current) use of selective estrogen receptor modulators (SERMs)
The 2025 edition of ICD10-CM Z79.810 became effective on October 1, 2024.
This is the American ICD10-CM version of Z79.810 - other international versions of ICD10 Z79.810 may differ.
Z79.810 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

Inclusion Term

Long term (current) use of raloxifene (Evista)
Long term (current) use of tamoxifen (Nolvadex)
Long term (current) use of toremifene (Fareston)

The following codes above Z79.810 contain annotation back-references that may be applicable to Z79.810:

Chapter: Z00-Z99 Factors influencing health status and contact with health services

Section: Z77-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status

Category: Z79 Long term (current) drug therapy

selective icd 10

receptor icd 10

estrogen icd 10

modulators icd 10

Billable/Specific Code

Browse other similar CM codes

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Please, give attribution to our website icd-10code.com